Katie Matt 3/24/25 Katie Matt 3/24/25

Aleta’s Novel T Cell Engagers

Katie Matt 6/24/24 Katie Matt 6/24/24

The 4-1BB CAR-T Enigma: who’s driving and where can they go?

Katie Matt 3/25/24 Katie Matt 3/25/24

Recent CAR-T Clinical Studies in Glioma and Glioblastoma Patients

Katie Matt 8/22/23 Katie Matt 8/22/23

The PD-1/PD-L1 Pathway and CAR-T Cells: Stop Making Sense

Katie Matt 7/31/23 Katie Matt 7/31/23

A Deep Dive Into The Use of Cytokines With CAR T Cells

Aleta’s CEO/CSO Paul Rennert does a deep dive on the clinical cytokine space and the efforts to deploy cytokines in context of CAR T Engagers.